ReviewNaunyn-Schmiedeberg's archives of pharmacology2025
The therapeutic effects of Plantago major and its main constituents on respiratory diseases: a narrative review.
Review in Naunyn-Schmiedeberg's archives of pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Phytochemical investigation and evaluation of anti-inflammatory and wound healing activities of Plantago major subsp. intermedia (Gilib.) Lange.BMC complementary medicine and therapies · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Herbal medicines have been proposed as adjuvant treatment for respiratory diseases. One such agent is Plantago major (P. major). Therefore, this review aims to gather the most recent experimental and clinical evidence on P. major's therapeutic effects on respiratory diseases. This review search was performed through Web of Science, PubMed, Google Scholar, and Scopus from the 1990s to March 2024. In experimental studies, the effects of P. major on inflammation, infection, asthma, and COPD models were established. In clinical studies, a significant reduction in cough and wheezing, increases in FEV1 and FVC in asthmatic patients, a rapid effect on signs and symptoms of bronchitis, and antiviral effects were observed. Despite in vitro and animal studies, there are limited clinical studies on the respiratory effects of P. major on humans. Therefore, designing more clinical studies to identify the respiratory effects of the plant and its derivatives should be considered.
Indexed as
Identifiers
40663154What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.